![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Seeks Information on Abuse-Deterrent CNS Stimulants
FDA Seeks Information on Abuse-Deterrent CNS Stimulants
September 27, 2019
The FDA has created a docket on abuse-deterrent formulas of central nervous system (CNS) stimulants and is seeking public comments.
The agency wants to know more about the potential benefits, harms and history of use of the stimulants commonly used to treat ADHD, and if abuse-deterrent formulas could reduce prescription stimulant abuse.
Currently marketed CNS stimulants are made primarily of amphetamine salts and related compounds like methylphenidate and methamphetamine, to treat ADHD and sometimes, narcolepsy.
Upcoming Events
-
21Oct